Most recent by Brian T. Hill MD, PhD
SPONSORED CONTENT
December 22, 2023
1 min watch
Save
VIDEO: Novel agents show 'significant trend' toward better responses for relapsed LBCL
In this video, Brian T. Hill, MD, PhD, discusses research that evaluated the effectiveness of chemo-immunotherapy against three novel combination therapies in the second line or later for patients with relapsed/refractory large B-cell lymphoma.
SPONSORED CONTENT
December 21, 2023
1 min watch
Save
VIDEO: Longer follow-up on CAR T-cell therapy for DLBCL shows durability and tolerability
In this video, Brian T. Hill, MD, PhD, discusses results of the phase 2 PILOT study of lisocabtagene maraleucel as second-line therapy for relapsed/refractory diffuse large B-cell lymphoma.
SPONSORED CONTENT
December 20, 2023
2 min watch
Save
VIDEO: Durability of response to bispecific antibodies 'encouraging' for lymphoma
In this video, Brian T. Hill, MD, PhD, discusses important research on bispecific antibodies for the treatment of lymphoma presented at ASH Annual Meeting and Exhibition.